Establishment of a National Cord Blood Banking Network through the National Marrow Donor Program (English)
- New search for: Kurtzberg, J.
- New search for: Creer, M.
- New search for: Halet, M.
- New search for: Welte, K.
- New search for: Boo, M.
- New search for: Confer, D.
- New search for: Chell, J.
- New search for: Kurtzberg, J.
- New search for: Creer, M.
- New search for: Halet, M.
- New search for: Welte, K.
- New search for: Boo, M.
- New search for: Confer, D.
- New search for: Chell, J.
In:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
;
11
, 2
;
39
;
2005
-
ISSN:
- Article (Journal) / Print
-
Title:Establishment of a National Cord Blood Banking Network through the National Marrow Donor Program
-
Contributors:Kurtzberg, J. ( author ) / Creer, M. ( author ) / Halet, M. ( author ) / Welte, K. ( author ) / Boo, M. ( author ) / Confer, D. ( author ) / Chell, J. ( author )
-
Published in:BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION ; 11, 2 ; 39
-
Publisher:
- New search for: AMERICAN SOCIETY FOR BLOOD AND MARROW
-
Publication date:2005-01-01
-
Size:39 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 617.4
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 617.4 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 11, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Hematopoietic stem cell transplantation 2005| 2005
- 1
-
Mesenchymal stem cells induce division arrest anergy of activated T cellsGlennie, S. J. / Soeiro, I. / Dyson, J. / Lam, E. / Dazzi, F. et al. | 2005
- 1
-
Genetic polymorphisms in the genes encoding human interleukin receptor 7A (IL-7RA): Prognostic significance in allogeneic stem cell transplantation (SCT)Shamim, Z. / Ryder, L. P. / Heilmann, C. / Madsen, H. O. / Svejgaard, A. / Jacobsen, N. / Muller, K. et al. | 2005
- 1
-
In vivo functional imaging of hematopoietic stem cell engraftmentStein, J. / Askenasy, N. / Farkas, D. / Yaniv, I. et al. | 2005
- 2
-
Allogeneic stem cell transplantation (allo SCT) in adult ALL: Does prophylactic donor lymphocyte infusion (DLI) improve survival?Arnold, R. / Lutz, C. / Neuburger, S. / Tamm, I. / Rosen, O. / Dö / rken, B. / Massenkeil, G. et al. | 2005
- 2
-
Bone marrow cells for cardiac repairKeating, A. et al. | 2005
- 2
-
Adult transplant outcomes, single versus pooled cord blood transplantsWofford, J. D. / Regan, D. M. / Creer, M. H. et al. | 2005
- 2
-
Results of the Cord Blood Transplantation Study (COBLT): Clinical outcomes of 193 unrelated donor umbilical cord blood transplantation in pediatric patients with malignant conditionsKurtzberg, J. / Carter, S. L. / Baxter-Lowe, L. A. / Feig, S. A. / Guinan, E. C. / Kamani, N. R. / Kapoor, N. / Delaney, C. / Haut, P. R. / Wall, D. et al. | 2005
- 3
-
Sirolimus and tacrolimus as graft-versus-host disease prophylaxis in allogeneic stem cell transplantation: The Dana Farber Cancer Institute experienceCutler, C. / Li, S. / Kim, H. T. / Alyea, E. / Ho, V. / Lee, S. J. / Soiffer, R. / Antin, J. et al. | 2005
- 3
-
Oral mucositis incidence and severity after methotrexate- and non-methotrexate-containing GVHD prophylaxis regimensCutler, C. / Li, S. / Kim, H. T. / Laglenne, P. / Ford, C. / Ho, V. / Lee, S. / Alyea, E. / Soiffer, R. / Sonis, S. et al. | 2005
- 3
-
The role of reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparisonDe Lavallade, H. / Mohty, M. / Faucher, C. / Vey, N. / Coso, D. / Stoppa, A. M. / Gastaut, J. A. / Ladaique, P. / Chabannon, C. / Blaise, D. et al. | 2005
- 4
-
Adoptive transfer of in vitro-generated T cell precursors enhances posttransplant donor T cell reconstitution in recipients of an allogeneic hematopoietic stem cell transplantationZakrzewski, J. L. / Kochman, A. / Muriglan, S. J. / Lu, S. / Kim, T. D. / Zuniga-Pflucker, J. C. / Alpdogan, O. / van den Brink, M. R. et al. | 2005
- 4
-
Sirolimus and thrombotic microangiopathy after allogeneic stem cell transplantationCutler, C. / Henry, N. L. / Li, S. / Kim, H. T. / Magee, C. / Alyea, E. / Ho, V. / Soiffer, R. / Antin, J. et al. | 2005
- 4
-
Palifermin (a RHUKGF molecule) is safe and well tolerated in patients with hematologic malignancies (HM) undergoing high-dose chemoradiotherapy (HD-CRT) followed by allogeneic hematopoietic stem cell transplantation (HSCT)Blazar, B. R. / Weisdorf, D. J. / DeFor, T. E. / Goldman, A. I. / Silver, S. / Ferrara, J. L. et al. | 2005
- 5
-
A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignanciesAndritsos, L. A. / Edwards, T. / Sempek, D. / Calandra, G. / Badel, K. / Vij, R. / DiPersio, J. F. / Devine, S. M. et al. | 2005
- 5
-
Phase I study of a neutralizing monoclonal anti-CTLA4 antibody (MDX-010) in patients with relapse of malignancy after allogeneic hematopoietic stem cell transplantationBashey, A. / Medina, B. / Zhong, R. K. / Zhou, J. H. / Carrier, E. / Castro, J. / Holman, P. / Lane, T. A. / Sun, C. / Lowy, I. et al. | 2005
- 6
-
Pegfilgrastim alone successfully mobilizes peripheral CD34+ cells in chemotherapy naive subjects with solid tumors: Initial results of a phase 1–2 studyPettengell, R. / Willis, F. / Woll, P. J. / Desborough, C. / Buchanan, K. et al. | 2005
- 6
-
Cellular immunotherapy utilizing low-dose irradiation, bone marrow transplantation. And donor lymphocyte infusions for acute leukemia: A phase II studyColvin, G. A. / Rathore, R. / Lum, L. G. / Abedi, M. / Ballen, K. K. / Dey, B. R. / Elfenbein, G. J. / Quesenberry, P. J. et al. | 2005
- 6
-
Rituximab does not inhibit chemo-mobilization of HPC or engraftment following autologous transplant for lymphomaKaufman, J. L. / Lonial, S. / Hicks, M. / Langston, A. / Flowers, C. / Lechowicz, M. J. / Khoury, H. / Waller, E. K. et al. | 2005
- 6
-
Pretreatment with imatinib mesylate increases transplant-related mortality after allogeneic transplantationZander, A. R. / Zabelina, T. / Renges, H. / Schieder, H. / Fehse, N. et al. | 2005
- 7
-
Identification and tissue distribution of antigen-specific recipient anti-donor CD8+ T cells that resist hematopietic engraftment following MHC-matched allogeneic progenitor cell transplantsShatry, A. M. / Levy, R. B. et al. | 2005
- 7
-
Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic al amyloidosis (AL)Cohen, A. D. / Zhou, P. / Reich, L. / Fircanis, S. / Drake, L. / Hedvat, C. / Teruya-Feldstein, J. / Filippa, D. A. / Fleisher, M. / Comenzo, R. L. et al. | 2005
- 7
-
Clinical trials of intracoronary bone marrow cell transfer after myocardial infarction: The Hannover experienceDrexler, H. et al. | 2005
- 8
-
Immunological autologous stem cell graft engineering using combination G-CSF and aldesleukin (IL-2) in patients with non-Hodgkin’s lymphomaMicallef, I. N. / Markovic, S. N. / Geyer, S. / Porrata, L. F. / Ansell, S. M. / Inwards, D. J. / Gastineau, D. A. / Padley, D. J. / Armstrong, A. S. / Litzow, M. R. et al. | 2005
- 8
-
Inhibitory effects of cytotoxicity of cytokine activated and expanded human CD8+ T cells by a human NKG2D alternative splice variantKarimi, M. A. / Cao, T. / Soares, L. / Negrini, R. S. et al. | 2005
- 8
-
Rabbit IgG levels in patients receiving thymoglobulin as part of conditioning before unrelated-donor allogeneic stem cell transplantationRemberger, M. / Sundberg, B. et al. | 2005
- 9
-
Generation of tolerogenic dendritic cells and regulatory T cells through intravenous delivery of autologous photopheresis-induced apoptotic cellsCampbell, K. / Huber, J. / Rosenberg, A. / Peters, C. / Harriman, G. / Strobl, F. / Peritt, D. / Schwarz, A. / Maeda, A. / Schwarz, T. et al. | 2005
- 9
-
Acute and chronic graft-versus-host disease (GVHD) in patients undergoing allogeneic BMT for thalassaemia majorGeorge, B. / Mathews, V. / Viswabandhya, A. / Kavitha, N. / Srivastava, A. / Chandy, M. et al. | 2005
- 9
-
Complexity of the human acute myeloid leukemia stem cell compartment: Implications for therapyDick, J. E. et al. | 2005
- 9
-
Pretransplant recipient blood CD14+ preDC levels correlate with increased acute GVHD after allogeneic PBSC transplantationArpinati, M. / Giannoullia, P. / Chirumbolo, G. / Bonifazi, F. / Saunthararajah, Y. / Bandini, G. / Stanzani, M. / Baccarani, M. / Rondelli, D. et al. | 2005
- 10
-
Sequential blockade and engagement of costimulatory pathways: A potential strategy for amplifying graft-versus-leukemia responses without graft-versus-host diseaseChakraverty, R. / Buchli, J. / Zhao, G. / Hsu, R. / Croft, M. / Sykes, M. et al. | 2005
- 10
-
Rituxan for steroid-refractory chronic GVHDCutler, C. / Miklos, D. / Lee, S. J. / Woo, S. B. / Treister, N. / Bienfang, D. / Klickstein, L. / Levin, J. / Windawi, S. / Pasek, M. et al. | 2005
- 10
-
Clonal expansion but impaired trafficking of GVH-reactive T cells following delayed DLI to mixed chimerasChakraverty, R. / Buchli, J. / Zao, G. / Lin, C. / Sykes, M. et al. | 2005
- 11
-
Hyperacute GVHD: Analysis of risk factors, clinical manifestations, and outcomesCouriel, D. R. / Saliba, R. / De Lima, M. J. / Hosing, C. / Andersson, B. / De Jesus, J. / Mickler, K. / Hsu, Y. / Shpall, E. J. / Neumann, J. et al. | 2005
- 11
-
Assessing donor chimerism level among CD3 T, CD4 T, CD8 T, and NK cells predicts subsequent graft rejection, GVHD, and relapse after allogeneic HCT with nonmyeloablative conditioningBaron, F. / Storb, R. / Gooley, T. / Sandmaier, B. / Gisburne, S. / Shin, S. / Stroup, P. / Baker, J. / Maris, M. / Maloney, D. et al. | 2005
- 12
-
Brain tumor stem cellsDirks, P. B. et al. | 2005
- 12
-
After MHC-matched allografting, host-derived langerhans cells (LCs) persist in skin and cutaneous lymph nodes in the steady-state and are the targets of DLI-mediated alloresponseDurakovic, N. / Bezak, K. B. / Skarica, M. / Fuchs, E. J. / Luznik, L. et al. | 2005
- 12
-
Allogeneic B cell response to H-Y minor histocompatibility antigens after donor lymphocyte infusion correlates with disease responseMiklos, D. B. / Miller, K. / Kim, H. T. / Lee, S. J. / Alyea, E. P. / Cutler, C. / Antin, J. H. / Soiffer, R. J. / Ritz, J. et al. | 2005
- 12
-
In vitro rapamycin and costimulation generates Th1/Tc1 or Th2/Tc2 central memory effectors: Differential regulation by in vivo rapamycin after allogeneic BMTFowler, D. H. / Foley, J. / Jung, U. et al. | 2005
- 13
-
In vivo trafficking of CD4+CD25+ regulatory T-cells in allogeneic recipients using bioluminescence imagingNguyen, V. H. / Wieland, C. / Contag, C. / Negrin, R. et al. | 2005
- 13
-
Particular HLA-DPB1 allele mismatches predict for worse overall survival in recipients of unrelated donor haematopoietic stem cell transplantsShaw, B. E. / Marsh, S. G. / Mayor, N. P. / Madrigal, A. et al. | 2005
- 13
-
Bone marrow-derived mesenchymal stem cells augment tissue engineered enterocytesGandia, C. / Yu, H. / Santiago, S. / Coats, E. / Defaria, W. / Ruiz, P. / Tzakis, A. / Kleiner, G. I. et al. | 2005
- 14
-
HLA mismatch and clinical outcome after unrelated donor (URD) non-myeloablative hematopoietic stem cell transplantation (NST)Ho, V. T. / Kim, H. T. / Windawi, S. / Liney, D. / Milford, E. / Cutler, C. / Lee, S. J. / Soiffer, R. J. / Antin, J. H. / Alyea, E. P. et al. | 2005
- 14
-
Self-renewal and solid-tumor stem cellsClarke, M. F. et al. | 2005
- 14
-
Unrelated stem cell transplantation (SCT) for fanconi anemia(FA) using cyclophosphamide(CY)+ fludarabine(FLU)+ thymoglobuline(THYMO): Consecutive analysis of 20 patients treated at the same instituitionBonfim, C. M. / Bitencourt, M. A. / Setubal, D. C. / Funke, V. A. / Ruiz, J. / Aduan, M. / Dourado, D. / de Medeiros, C. R. / Zanis-Neto, J. / Pasquini, R. et al. | 2005
- 14
-
Factors influencing the success of unrelated stem cell donor (URD) searchHong, S. L. / Chitphakdithai, P. / Dodson, K. L. / Matlack, M. E. / Coppo, P. A. / Weisdorf, D. J. / Confer, D. L. / Karanes, C. et al. | 2005
- 15
-
Contributions of KIR genotype and HLA-C-encoded KIR ligands to the outcome of allogeneic hematopoietic stem cell transplantationFischer, J. / Ottinger, H. D. / Ferencik, S. / Schwan, M. A. / Middleton, P. G. / Grosse-Wilde, H. / Wernet, P. / Dickinson, A. M. / Uhrberg, M. et al. | 2005
- 15
-
Aspergillus fumigatus-specific cytotoxic T-cell lines generated through use of Asp f16 protein-spanning pools of overlapping pentadecapeptidesRamadan, G. / Davies, B. / Kurup, V. P. / Keever-Taylor, C. A. et al. | 2005
- 15
-
The generation of donor-derived virus-specific cytotoxic T lymphocytes reactive against cytomegalovirus and adenovirus antigens for clinical useBollard, C. M. / Leen, A. / Huls, H. / Myers, G. D. / Sili, U. / Rooney, C. M. / Helsop, H. E. et al. | 2005
- 16
-
Ex vivo expanded myeloid progenitor cells protect neutropenic mice from fungus infectionDomen, J. / Wahedi, M. / Danenberg, E. / Christensen, J. / Smith, S. / Fong, T. et al. | 2005
- 16
-
NK cell killer immunoglobulin receptor (KIR) reconstitution and interferon production after unrelated donor (URD) transplantation is altered by the T-cell content of the graft and correlates with acute GVHDCooley, S. / McCullar, V. / Wangen, R. / Weisdorf, D. J. / Miller, J. S. et al. | 2005
- 16
-
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID miceDi Ianni, M. / Del Papa, B. / De Ioanni, M. / Terenzi, A. / Sportoletti, P. / Moretti, L. / Falzetti, F. / Bonifacio, E. / Martelli, M. F. / Tabilio, A. et al. | 2005
- 17
-
Early allogeneic stem cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: An intent-to-treat analysis of the long-term experience of the BGMT groupJourdan, E. / Boiron, J. M. / Dastugue, N. / Vey, N. / Marit, G. / Rigal Huguet, F. / Molina, L. / Fegueux, N. / Pigneux, A. / Recher, C. et al. | 2005
- 17
-
Limiting allogeneic bone marrow transplantation based on psychosocial criteria: A comparison of professional attitudesMcLellan, L. / Foster, L. / Kuczkowski, E. / Dabney, J. / Welsh, E. / Bell, K. / Rini, B. / Bates, J. / Curtis, J. / Bolwell, B. J. et al. | 2005
- 17
-
Introduction to graft-versus-host diseaseRingdé / n, O. et al. | 2005
- 17
-
HSCT family caregiver quality of life influenced by high caregiving strain and low predictability of caregivingEldredge, D. H. / Nail, L. M. / Grant, M. / Maziarz, R. T. et al. | 2005
- 18
-
Total body irradiation (TBI) and G-CSF-combined high-dose cytarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia (AML) and advanced myelodysplastic syndrome (MDS)Mori, T. / Yokoyama, A. / Aisa, Y. / Yamane, A. / Yamazaki, R. / Nakazato, T. / Ikeda, Y. / Okamoto, S. et al. | 2005
- 18
-
Repair of Crohn’s disease with embryonic stem cellsFeng, Z. / Arrunategui-Correa, V. / Kim, H. S. / Carrier, E. et al. | 2005
- 18
-
The use of autologous LMP2-specific cytotoxic T lymphocytes for the treatment of relapsed EBV+ Hodgkin’s disease and non-Hodgkin’s lymphomaBollard, C. M. / Straathof, K. C. / Huls, H. / Gresik, V. / Carrum, G. / Gottschalk, S. / Gee, A. / Brenner, M. K. / Rooney, C. M. / Heslop, H. E. et al. | 2005
- 19
-
Human hematopoietic stem cells can be expanded ex vivo using recombinant TAT-HOXB4 proteinKrosl, G. / Giard, M. P. / Krosl, J. / Humphries, R. K. / Sauvageau, G. / Roy, D. C. et al. | 2005
- 19
-
Abdominal CT in the clinical evaluation of acute graft-versus-host disease (GVHD) of the gastrointestinal tract: Diffuse small intestine involvement is associated with poor outcomeShimoni, A. / Hertz, M. / Yeshurun, M. / Portnoy, O. / Hardan, I. / Amitai, M. / Nagler, A. / Apter, S. et al. | 2005
- 19
-
Safety and tolerability of antibacterial prophylaxis during the postengraftment phase after myeloablative hematopoietic stem cell transplantationBubalo, J. S. / Hayes-Lattin, B. / Curtin, P. T. / Leis, J. F. / Mauro, M. J. / Simic, A. / Dunn, A. / Subbiah, N. / Allen, B. / Balleison, S. et al. | 2005
- 20
-
Hematologic effects of linezolid in febrile neutropenic patientsJaksic, B. / Hartman, C. S. / Leonard, L. B. / Tack, K. J. et al. | 2005
- 20
-
Immunopathogenic mechanisms of acute post-HSCT lung injury: A syngeneic murine model induced by occult Pneumocystis carinii infection and TBIBruckner, L. / Finkelstein, J. / Gigliotti, F. et al. | 2005
- 21
-
One year follow up of 71 leukemic patients who received fludarabine and busulfan (FluBup) as myeloablative conditioning regimen for allogeneic PBSCTIravani, M. / Tavakoli, M. / Shamshiri, A. R. / Mousavi, A. / Bahar, B. / Ghavamzadeh, A. et al. | 2005
- 21
-
Pathogenesis of graft-versus-host-diseaseSale, G. E. et al. | 2005
- 21
-
Allogeneic bone marrow transplantation in β-thalassaemia—single center studyHashmi, K. U. / Raza, S. / Khattak, B. K. / Ahmed, P. / Hussain, I. et al. | 2005
- 21
-
Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: The Mexican experienceGomez-Almaguer, D. / Vela-Ojeda, J. / Jaime-Perez, J. C. / Gutierrez-Aguirre, C. H. / Cantu-Rodriguez, O. G. / Sobrevilla-Calvo, P. / Rivas-Vera, S. / Gomez-Rangel, J. D. / Ruiz-Arguelles, G. J. et al. | 2005
- 21
-
Facilitating cell (FC)-mediated alloengraftment occurs in the context of in vivo regulatory T-cell inductionShinde Patil, V. R. / Colson, Y. L. et al. | 2005
- 22
-
The results of risk adapted pre-emptive therapy of CMV infection with ganciclovir in 169 patients, after allogeneic hematopoietic stem cell transplantation in Hematology-Oncology and BMT Research CenterIravani, M. / Faghih, A. H. / Shamshiri, A. R. / Toutounchi, M. / Tavakoli, M. / Mousavi, A. / Bahar, B. / Alimoghadam, K. / Jahani, M. / Ghavamzadeh, A. et al. | 2005
- 22
-
In vivo T cell depleted unrelated allogeneic stem cell transplantation with a reduced intensity regimen in patients with advanced hematologic malignanciesMagalhaes-Silverman, M. / Carter, T. / Gingrich, R. / Hohl, R. / Schlueter, A. et al. | 2005
- 22
-
Myeloablative conditioning with fludarabine and busulfan for allogeneic PBSCT in chronic phase CMLIravani, M. / Tavakoli, M. / Shamshiri, A. R. / Mousavi, A. / Bahar, B. / Jahani, M. / Ghavamzadeh, A. et al. | 2005
- 23
-
Umbilical Cord Blood Transplants (UCBT). Evaluation of chimerism and survival in relation to CD34 or mononuclear cell (MNC) dose infused. The Children’s Memorial Hospital (CMH) experienceMerchant, M. / Olszewski, M. / Duerst, R. / Huang, W. / Jacobsohn, D. / Kletzel, M. et al. | 2005
- 23
-
Hematopoietic cell transplantation (HCT)-specific-comorbidity index: A new tool for risk assessment before allogeneic HCTSorror, M. L. / Maris, M. B. / Storb, R. F. / Baron, F. / Sandmaier, B. M. / Maloney, D. G. / Barry, S. E. et al. | 2005
- 24
-
T-cell alloreactivity in hematopoietic stem cell transplantationHansen, J. A. et al. | 2005
- 24
-
Long term infectious complications following reduced intensity conditioning (RIC) allogeneic HLA-identical sibling transplantation (allo-SCT)Etienne, A. / Mohty, M. / Faucher, C. / Ferrando, M. / Benramdane, R. / Zandotti, C. / Collet, L. / Vey, N. / Stoppa, A. M. / Coso, D. et al. | 2005
- 24
-
Dramatic change in treatment related mortality (TRM) for allogeneic stem cell transplantation (SCT) during recent years. A one centre analysisHeilmann, C. / Laursen, H. B. / Muller, K. / Haastrup, E. / Jacobsen, N. et al. | 2005
- 24
-
Effects of natural killer (NK) cells on allogeneic bone marrow transplantation (BMT) in fetal and newborn miceBhattacharyya, S. / Cowan, M. J. et al. | 2005
- 25
-
Improvement of matched sibling donor engraftment with sirolimus added to a non-myeloablative conditioning regimenClaxton, D. F. / Ehmann, C. / Shaffer, M. / Rybka, W. et al. | 2005
- 25
-
Imatinib only for molecular relapse is not sufficient to achieve a durable complete chimeric status and molecular remission after allo HCT in CMLSoydan, E. / Civriz, S. / Beksac, M. / Koc, H. / Gurman, G. / Ilhan, O. / Arat, M. et al. | 2005
- 25
-
Can we consider fludarabine/ full dose I.V. busulfan a reduced intensity conditioning regimen?Chunduri, S. / Jessop, E. / Dobogai, L. / Peace, D. / Saunthararajah, Y. / Chen, Y. H. / Mahmud, N. / Maynard, V. / Hoffman, R. / Rondelli, D. et al. | 2005
- 26
-
Unrelated cord blood transplantation with myeloablative conditioning for adult patients with hematological malignanciesYamane, A. / Mori, T. / Aisa, Y. / Nakazato, T. / Yamazaki, R. / Ikeda, Y. / Okamoto, S. et al. | 2005
- 26
-
Alemtuzumab immunotherapy provides effective cytoreduction prior to allogeneic stem cell transplantation for refractory lymphoproliferative disordersVoralia, M. / Hasegawa, W. / McAllister, R. / Evjen, A. / Briggs, S. / Doell, H. / Danyluk, P. et al. | 2005
- 26
-
The frequency of early complications after allogeneic hematopoietic stem cell transplantation (HSCT) with myeloablative (MA) and non-myeloablative (NMA) conditioning regimenGolovchenko, R. A. / Moiseev, S. I. et al. | 2005
- 27
-
Factors associated with clinical outcomes of 483 allogeneic peripheral blood stem cell transplants (PBSCT) in BrazilVigorito, A. C. / Aranha, F. J. / Oliveira, G. B. / Eid, K. A. / Lodi, F. M. / Azevedo, W. M. / Colturato, V. / De Souza, M. P. / Barros, J. C. / Bittencourt, H. et al. | 2005
- 27
-
Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failureChewning, J. H. / Castro-Malaspina, H. R. / Hsu, K. / Jakubowski, A. A. / Kernan, N. A. / Papadopoulos, E. B. / Perales, M. A. / Prockop, S. E. / Small, T. N. / Vandenbrink, M. R. et al. | 2005
- 27
-
Myeloablative vs non-myeloablative conditioning with allogeneic stem cell transplantation for high risk non-Hodgkin’s lymphoma: Similar outcomes despite differences in disease riskHewitt, M. / Porter, D. L. / Hummel, K. / McAlee, A. / Phillips, J. / Stadtmauer, E. / Schuster, S. / Luger, S. / Nasta, S. / Tsai, D. et al. | 2005
- 28
-
Stable long term engraftment and amelioration of clinical phenotype following hematopoietic stem cell transplantation from a matched sibling donor for sickle cell disease using a reduced intensity conditioning regimenKrishnamurti, L. / Wu, C. / Baker, S. / Yeager, A. M. / Wagner, J. E. et al. | 2005
- 28
-
Intravenous busulfan dosed four times daily or once daily as part of the standard BuCy preparative regimen for allogeneic stem cell transplantationShaughnessy, P. J. / Bachier, C. / Alexander, L. / Bowen, B. / LeMaistre, C. F. et al. | 2005
- 28
-
High relapse rate following alemtuzamab use in allogeneic transplants for myeloid hematologic malignanciesShea, T. C. / Serody, J. / Gabriel, D. / Comeauu, T. / Morris, D. / Irons, R. / Harvey, D. / Sharf, A. / Krasnov, C. / Dunphy, C. et al. | 2005
- 28
-
Innovations in autologous transplantation for hematologic malignancyForman, S. J. et al. | 2005
- 29
-
Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AMLHsu, K. C. / Malkki, M. / Gooley, T. A. / Dupont, B. / Petersdorf, E. W. et al. | 2005
- 29
-
Transfusional iron burden after bone marrow transplantationJastaniah, W. A. / Harmatz, P. / Pakbaz, Z. / Singer, T. / Fischer, R. / Vichinsky, E. / Walters, M. C. et al. | 2005
- 30
-
Absence of CD80/86 expression on donor bone marrow is sufficient to circumvent T cell mediated resistance following experimental “mini” MHC-matched allogeneic BMTZimmerman, Z. F. / Levy, R. B. et al. | 2005
- 30
-
Descriptive analysis of changing toxicity profiles for 30 and 100 day mortality after matched related donor (MRD) allogeneic (allo) hematopoietic stem cell transplantation (HSCT) using po vs iv busulfan (BU) based conditioning regimensGupta, S. / Cole, S. W. / Salzman, D. E. / Ashraf, K. / Aggarwal, C. / Vaughan, W. P. et al. | 2005
- 30
-
The requirement of MHC class II for donor CD4+CD25+ T cell-mediated support of early allogeneic progenitor cell engraftmentHanash, A. M. / Levy, R. B. et al. | 2005
- 31
-
Lack of impact of comorbidities on outcomes of allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS)Wong, R. S. / Shahjahan, M. / Alamo, J. / de Lima, M. / Khouri, I. / Gajewski, J. / Andersson, B. / Champlin, R. / Giralt, S. et al. | 2005
- 31
-
Long-term follow up of patients who experienced graft failure post allogeneic progenitor cell transplantationRondon, G. / Khouri, I. / Giralt, S. / Chan, K. / McMannis, J. / Champlin, R. / Shpall, E. et al. | 2005
- 31
-
Once daily intravenous (IV) busulfan (Bu) containing preparative regimens for hematopoietic stem cell transplantation (HSCT): Low incidence of Hepatic Veno-Occlusive Disease (HVOD) and improved early survival in a single center’s experienceBenn, H. / Amin, A. / Susan, H. C. / Kramek, D. / Janbay, N. / Randhawa, D. / Nath, R. et al. | 2005
- 32
-
Opportunistic infections are the major cause of mortality after nonmyeloablative unrelated bone marrow transplantation with alemtuzumab, fludarabine and melphalanCarroll, M. P. / BuchBarker, D. / Schwartz, R. / Agha, M. E. / Tompkins, C. / Baileys, K. / O’ / Connell, K. / Donnenberg, A. D. / Yeager, A. M. et al. | 2005
- 32
-
Calculating iv busulfan (ivBu) dose using body surface area predicts measured drug exposure more accurately than dosing in mg/kg but does not eliminate the need for pharmacokinetics (PK) to obtain dosing precisionNance, A. G. / Vaughan, W. P. / Wang, W. / Salzman, D. E. et al. | 2005
- 33
-
Regimen related toxicity after thiotepa, cyclophosphamide and intravenous busulfan as conditioning for allogeneic stem cell transplantationSanz, J. / Sanz, G. F. / Moscardoó / F. / Cupelli, L. / Montesinos, P. / Puig, N. / Lorenzo, I. / Benlloch, L. / Jarque, I. et al. | 2005
- 33
-
Influence of killer immunoglobulin-like receptor (KIR) matching on achievement of T-cell (CD3+) complete donor chimerism (CDC) in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT)Sobecks, R. / Ball, E. / Theil, K. / Brown, S. / Rybicki, L. / Maciejewski, J. / Kalaycio, M. / Pohlman, B. / Baker, J. / Bernhard, L. et al. | 2005
- 33
-
Absence of prior infections is strongest predictor for survival after alternate donor hematopoietic cell transplantation in patients with Fanconi anemiaMacMillan, M. L. / Auerbach, A. D. / Champagne, M. A. / DeFor, T. E. / Slungaard, A. / Weisdorf, D. J. / Wagner, J. E. et al. | 2005
- 33
-
Transplantation after reduced intensity conditioning in patients with acute myeloid leukaemia in SwedenAschan, J. / Ringdé / n, O. / Wahlin, A. / Wernstedt, P. / Brune, M. et al. | 2005
- 34
-
Replacement donor program: More than protecting stem cell donors from multiple donations for different patientsBaier, D. M. / Gawellek, A. / Rutt, C. et al. | 2005
- 34
-
Long-term outcome after marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia using cyclophosphamide and in-vivo anti-CD52 monoclonal antibodiesGupta, V. / Ball, S. E. / Yi, Q. L. / Sage, D. / McCann, S. R. / Lawler, M. / Ortin, M. / Freires, M. / Hale, G. / Waldmann, H. et al. | 2005
- 34
-
Strategies to enhance the therapeutic efficacy of autologous hematopoietic stem cell transplantation by posttransplantation adoptive transfer of T cells with engineered graft-versus-tumor activityJensen, M. et al. | 2005
- 34
-
Less transplant-related mortality with variable intensity conditioning than non-myeloablative conditioning in unrelated and related adult allogeneic transplant recipientsBigelow, C. L. / Elkins, S. / Hardy, C. L. / Files, J. C. et al. | 2005
- 35
-
Choosing the patient for ambulatory stem cell transplantationCantu-Rodriguez, O. G. / Gutierrez-Aguirre, C. H. / Gonzalez-LLano, O. / Jaime-Perez, J. C. / Salazar-Riojas, R. / Martinez-Gonzalez, O. L. / Gomez-Almaguer, D. et al. | 2005
- 35
-
The hematopoietic cell transplantation database at dbMHCHelmberg, W. / Malkki, M. / Feolo, M. / Hoffman, D. / Petersdorf, E. et al. | 2005
- 35
-
In vivo spatial and temporal analyses in mice reveal redundancy of lymphoid tissues in inducing acute GVHD after allogeneic hematopoietic cell transplantationBeilhack, A. / Schulz, S. / Baker, J. / Beilhack, G. F. / Wieland, C. B. / Baker, E. M. / Herman, E. I. / Landan, G. / Olson, J. A. / Cao, Y. A. et al. | 2005
- 36
-
NK cell alloreactivity is an important mediator of costimulation-blockade-resistant rejection during allogeneic transplantationKean, L. S. / Hamby, K. / Coley, S. / Lee, E. / Adams, A. / Pearson, T. / Larsen, C. et al. | 2005
- 36
-
Bone marrow transplantation for dyskeratosis congenita: Analysis of complications and long term follow-upBonfim, C. M. / Bitencourt, M. A. / Funke, V. A. / Setubal, D. C. / Ruiz, J. / Zanis-Neto, J. / deMedeiros, C. R. / Silva, R. L. / Pasquini, R. et al. | 2005
- 36
-
The impact of age and obesity on plasma busulfan levelsIm, E. K. / Cronin, S. / Levine, J. E. / Braun, T. / Yanik, G. / Reynolds, C. / Uberti, J. P. / Ferrara, J. L. / Hutchinson, R. J. et al. | 2005
- 37
-
Human herpesvirus 6 manifesting as encephalitis in hematopoietic progenitor cell recipient after reduced intensity allogeneic transplantationNg, N. / Devoe, C. / John, V. / Bayer, R. L. et al. | 2005
- 37
-
Peri-transplant imatinib administration results in significant mortality of recipients of allogeneic hematopoietic stem cell transplants due to impaired bone marrow recoveryKeating, A. R. / McGoldrick, S. / Kochman, A. / Eng, J. M. / Hubbard, V. M. / van den Brink, M. R. et al. | 2005
- 37
-
A multi-institutional study of extracorporeal photoimmune therapy (ECP) with UVADEX® for the prevention of acute GVHD in patients (pts) undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation (AHCT)Abhyankar, S. / Shaughnessy, P. J. / Bolwell, B. J. / van Besien, K. / Mistrik, M. / Grigg, A. / Dodds, A. / Prince, H. M. / Machado, A. / Thienel, U. et al. | 2005
- 38
-
Prognostic factors for allogeneic stem cell transplantation (ASCT) for untreated first relapse of acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS)Alamo, J. G. / Shahjahan, M. / Wong, R. S. / de Lima, M. / Khouri, I. / Gajewski, J. / Couriel, D. / Andersson, B. S. / Anderlini, P. / Champlin, R. et al. | 2005
- 38
-
Pure red cell aplasia (PRCA) following ABO-incompatible allogeneic bone marrow transplantationSethi, S. / Hamadani, M. H. / Kamble, R. / Kharfan-Dabaja, M. / Ozer, H. / Selby, G. S. et al. | 2005
- 38
-
CD4+Vβ11+ T cells exhibit limited TCR-α repertoire diversity in the miHA-matched C57BL/6 → BALB.B model of graft-versus-host diseaseDiRienzo, C. G. / Friedman, T. / Korngold, R. et al. | 2005
- 39
-
Establishment of a National Cord Blood Banking Network through the National Marrow Donor ProgramKurtzberg, J. / Creer, M. / Halet, M. / Welte, K. / Boo, M. / Confer, D. / Chell, J. et al. | 2005
- 39
-
Development of graft-versus-host disease depends upon establishment of complete donor T cell chimerism after T cell depleted, reduced intensity hematopoietic stem cell transplantationHardy, N. M. / Steinberg, S. M. / Krumlauf, M. / Cvitkovic, R. / Castro, K. / Hakim, F. / Carter, C. / Read, E. J. / Leitman, S. / Gress, R. et al. | 2005
- 40
-
Significant decline in pulmonary engraftment syndrome after nonmyeloablative allogeneic hematopoietic cell transplantation associated with less amphotericin use for febrile neutropeniaDonohue, T. / Gorak, E. / McGettigan, C. / Morgan, T. / Fadell, A. / Srinivasan, R. / Childs, R. et al. | 2005
- 40
-
Innovations in preparative regimens for autologous hematopoietic cell transplantationAppelbaum, F. R. et al. | 2005
- 40
-
Generation of CMV specific cytolytic CD4+ and CD8+ T-cells by sensitization with a single pentadecapeptide of CMV pp65 containing both MHC class I and class II epitopesTrivedi, D. / Koehne, G. / Barnett, L. / Doubrovina, E. / O’ / Reilly, R. et al. | 2005
- 40
-
Low hemoglobin level pre-BMT is associated with higher RBC transfusion rates and poorer survival in allogeneic BMT recipientsHuebsch, L. / Toze, C. / Roy, J. / McDiarmid, S. / Fergusson, D. / Hutton, B. / Messner, H. et al. | 2005
- 41
-
Silencing human NKG2D, DAP10 and DAP12 reduces cytotoxicity of In vivo activated CD8+ T and NK cellsKarami, M. A. / Cao, T. M. / Baker, J. / Verneris, M. R. / Negrin, R. S. et al. | 2005
- 41
-
Evaluation of the structural basis of T cell allorecognition using recombinant HLA class I multimersOosten, L. E. / Whitelegg, A. / Jordan, S. / Madrigal, A. J. / Goulmy, E. / Barber, L. D. et al. | 2005
- 41
-
CD6-depleted mobilized stem cells for modification of HVG and GVH reactions after HLA-haploidentical marrow transplantationKolb, H. J. / Bigalke, I. / Simoes, B. / Falk, C. / Tischer, J. / Hill, W. / Ledderose, G. et al. | 2005
- 41
-
The haploimmunostorm syndrome: A distinct clinical entity seen in HLA-mismatched cellular immunotherapyColvin, G. A. / Rathore, R. / Lum, L. G. / Abedi, M. / Ballen, K. K. / Dey, B. R. / Elfenbein, G. J. / Quesenberry, P. J. et al. | 2005
- 42
-
Sensitive and quantitative chimerism analysis in all patients with real-time PCRUzunel, M. / Ulf, S. / Jonas, M. / Petter, S. / Marie, S. / Dan, H. / Olle, R. et al. | 2005
- 42
-
Acute graft versus host disease after non-myeloablative allogeneic stem cell transplantation (NST) with low-dose TBI, fludarabine and antithymocyte globulin (ATG)Grosskreutz, C. L. / Scigliano, E. / Fruchtman, S. M. / Isola, L. M. et al. | 2005
- 42
-
Clinical relevance of recipient leukocyte infusion (RLI) therapySaito, T. I. / Sykes, M. et al. | 2005
- 43
-
Graft-versus-host disease after nonmyeloablative hematopoietic stem cell transplantationNa, I. I. / Shn, H. / Song, E. K. / Lee, K. W. / Yoon, S. S. / Lee, J. S. / Park, S. / Kim, B. K. et al. | 2005
- 43
-
Immune reconstitution: The major barrier to successful stem cell transplantationAntin, J. H. et al. | 2005
- 43
-
Prevention of graft versus host disease by antibody mediated depletion of activated dendritic cellsWilson, J. / Rice, A. M. / Hart, D. N. / Munster, D. J. et al. | 2005
- 43
-
A murine transplantation model of in vivo dendritic cell depletion to attenuate graft versus host diseaseTurner, B. E. / Burns, A. M. / Atkinson, K. / Munster, D. J. / Hart, D. N. / Rice, A. M. et al. | 2005
- 43
-
Use of infliximab/daclizumab combination for the treatment of acute and chronic graft versus host disease of the liver and gutRodriguez, V. / Trotz, B. / Anderson, P. M. / Arndt, C. A. / Allen, J. / Khan, S. P. et al. | 2005
- 44
-
Optimization of culture methods for the expansion of CD4+CD25+ regulatory T cells for potential clinical useKeever-Taylor, C. A. / Browning, M. B. / Johnson, B. D. / Behn, B. / Truitt, R. L. et al. | 2005
- 44
-
PRAME-specific CD8+ T cells are spontaneously present in a large proportion of healthy donors and leukemic HLA-A0201 patientsRezvani, K. / Tawab, A. / Kilical, Y. / Sconocchia, G. / Li, J. / Hensel, N. / Kurlander, R. / Barrett, J. et al. | 2005
- 44
-
Flow cytometry monitoring of amplified oligoclonal T-cell populations in peripheral blood (PBL) of graft versus host disease (GVHD) patients submitted to extracorporeal phototherapy (ECP): Impact on the outcome evaluationTassi, C. / Tazzari, P. L. / Ricci, F. / Conte, R. et al. | 2005
- 45
-
Irradiation influences endothelial cell function in vitro and in vivo: A possible role for IP10Cannella, L. / Laylor, R. / Marelli-Berg, F. / Dazzi, F. et al. | 2005
- 45
-
Suicide gene therapy for human T cell mediated graft versus host disease in a murine xenograft modelNervi, B. / Rettig, M. P. / Ritchey, J. / Walker, J. / Bauer, G. / Herrbrich, P. E. / Bonyhadi, M. L. / Nolta, J. A. / DiPersio, J. F. et al. | 2005
- 45
-
Twice-daily intravenous bolus tacrolimus infusion for acute graft-vs-host disease prophylaxisHayek, F. N. / Al-Ghawi, H. / Allen, J. / Baize, T. / Mudd, L. / Mehta, A. / Soni, S. / Cheerva, A. / Herzig, G. P. / Herzig, R. H. et al. | 2005
- 45
-
Stem cell mobilization with novel G-CSF analogues augment NKT cell restricted graft-versus-leukaemia effectsMorris, E. S. / MacDonald, K. P. / Rowe, V. / Banovic, T. / Kuns, R. D. / Olver, S. D. / Kienzle, N. / Porcelli, S. A. / Pellicci, D. G. / Godfrey, D. I. et al. | 2005
- 46
-
Human Langerhans cells in transplantation: Recipient cells survive conditioning but donor cells predominate at day 100Collin, M. P. / Booth, T. / Middleton, P. G. / Jackson, G. H. / Mackinnon, S. / Cook, G. / Cavet, J. / Wang, X. N. / Dickinson, A. M. et al. | 2005
- 46
-
Regulatory T cellsBlazar, B. R. / Taylor, P. A. et al. | 2005
- 46
-
The contribution of CCR1 expression on donor leukocytes to the development of experimental idiopathic pneumonia syndromeHildebrandt, G. C. / Choi, S. / Olkiewicz, K. M. / Corrion, L. A. / Chensue, S. W. / Liu, C. / Cooke, K. R. et al. | 2005
- 47
-
Cardiac manifestations of graft-versus-host diseaseGilman, A. L. / Rackley, C. / Goldman, F. / Serrano, A. / Chan, K. W. / Schultz, K. R. et al. | 2005
- 47
-
Reversal of severe graft-versus-host disease after non-myeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem cellsKhan, S. A. / Moreb, J. S. et al. | 2005
- 47
-
Relationship between race and risk of acute graft-versus-host diseaseKlumpp, T. R. / Jillella, A. P. / Ulicny, J. A. / Emmons, R. V. / Mangan, K. F. et al. | 2005
- 48
-
Suberoylanilide hydroxamic acid modulates the innate and allostimulatory responses of dendritic cells and regulates experimental acute graft-versus-host diseaseReddy, P. / Maeda, Y. / Lowler, K. / Liu, C. / Dinarello, C. / Ferrara, J. L. et al. | 2005
- 48
-
Extracorporeal photochemotherapy for (ECP) the treatment of chronic graft-versus-host diseaseCouriel, D. R. / Hosing, C. / Anderlini, P. / Ippoliti, C. / Hsu, Y. / Neumann, J. / De Lima, M. J. / Ghosh, S. / Rhodes, B. / Saliba, R. et al. | 2005
- 48
-
Mature T cells alone separate GVL from GVHD: The need for better controlsChen, B. J. / Son, J. / Cui, X. / Chao, N. J. et al. | 2005
- 49
-
Risk factors for the development of acute and chronic GvHD after allogeneic hematopoietic stem cell transplantation in children and adolescentsPeters, C. / Lawitschka, A. / Atarbaschi, A. / Fritsch, G. / Lion, T. / Rosenmayr, A. / Fischer, G. / Hoecker, P. / Gadner, H. / Matthes-Martiin, S. et al. | 2005
- 49
-
CC chemokine receptor 2 is involved in intestinal homing of alloreactive donor CD8+ T cells during GVHDTerwey, T. H. / Kochman, A. A. / Eng, J. M. / Hubbard, V. M. / Muriglan, S. J. / Waldman, E. D. / Zakrzewski, J. L. / Alpdogan, O. / van den Brink, M. R. et al. | 2005
- 50
-
Denleukin diftitox (Ontak) for the treatment of advanced steroid refractory graft-versus-host disease (SR-GVHD): A single institution experienceBubalo, J. S. / Maziarz, R. T. / Subbiah, N. / Curtin, P. T. / Simic, A. / Hayes-Lattin, B. M. / Schubach, S. E. / Jacoby, C. E. / Leis, J. F. et al. | 2005
- 50
-
Murine CIK cells show tumor specific cytolysis in CD107a based degranulation analysisBaker, J. / Schulz, S. / Beilhack, A. / Eftekhari, K. / Negrin, R. S. et al. | 2005
- 50
-
Analysis of gene expression profile in patients with acute graft versus host disease following haematopoietic stem cell transplantationTabellini, L. / Lin, M. T. / Fan, W. / Pogosova-Agadjanyan, E. / Stephens, B. / Zhao, L. P. / Radich, J. / Hansen, J. A. et al. | 2005
- 50
-
Separation of CD4+ T cell-mediated graft-versus-host responses from the graft-versus-leukemia effectLewandowski, A. M. / Friedman, T. M. / Korngold, R. et al. | 2005
- 51
-
Grade 2–4 acute graft-versus-host disease and extensive chronic graft versus host disease are associated with significantly decreased survival following reduced intensity allogeneic stem cell transplantationChan, G. W. / Klein, A. K. / Sprague, K. A. / Miller, K. B. / Foss, F. M. et al. | 2005
- 51
-
Methotrexate alters hematopoietic recovery and engraftment kinetics when added to cyclosporine for acute GVHD prophylaxis after reduced-intensity stem cell transplantationDean, R. M. / Fowler, D. H. / Odom, J. / Castro, K. M. / Kasten-Sportes, C. / Wilson, W. H. / Gress, R. E. / Bishop, M. R. et al. | 2005
- 51
-
Significance of one human leukocyte antigen mismatch on outcome of non-myeloablative allogeneic stem cell transplantation from related donors using the Mexican scheduleRuiz-Arguelles, G. J. / Lopez-Martinez, B. / Manzano, C. / Gomez-Rangel, J. D. / Lobato-Mendizabal, E. et al. | 2005
- 52
-
Successful unrelated umbilical cord blood transplantation for Shwachman-Diamond SyndromeVibhakar, R. / Rumelhart, S. / Tatman, D. / Radhi, M. / Goldman, F. et al. | 2005
- 52
-
Donor age and degree of HLA matching have a major impact on results of the unrelated haematopoietic cell transplantation (UD-HCT) for chronic myeloid leukaemia (CML)Carreras, E. / Jimenez, M. / Gomez-Garcia, V. / de la Camara, R. / Martin, C. / Martinez, F. / Iriondo, A. / Sanz, G. / Canizo, C. / Cabrera, R. et al. | 2005
- 52
-
Donor factors influencing unrelated volunteer donor selection for haematopoietic stem cell transplantationLittle, A. M. / Cleaver, S. / Maldonado Torres, H. / Marsh, S. G. / Bronwen, S. / Madrigal, A. et al. | 2005
- 53
-
Multiplexed genotyping of human minor histocompatibility antigensPietz, B. C. / DuChateau, B. K. / Warden, M. B. / Ellis, T. M. et al. | 2005
- 53
-
Interleukin-7 improves reconstitution of antiviral CD4 T cellsLu, H. / Zhao, Z. / Kalina, T. / Kiem, H. P. / Storek, J. et al. | 2005
- 53
-
Molecular characterization of HLA-A mismatches for modeling outcomes analysesBaxter-Lowe, L. A. / Maiers, M. / Spellman, S. / Fernandez-Vina, M. / Horowitz, M. / Haagenson, M. / Hurley, C. et al. | 2005
- 53
-
Impact of plasmacytoid dendritic cell recovery on outcome after reduced-intensity conditioning allogeneic stem cell transplantationMohty, M. / Blaise, D. / Faucher, C. / Bardou, V. J. / Gastaut, J. A. / Viens, P. / Olive, D. / Gaugler, B. et al. | 2005
- 54
-
De novo generation of CD4 T cells against viruses present in the host during immune reconstitutionKalina, T. / Lu, H. / Zhao, Z. / Kiem, H. P. / Storek, J. et al. | 2005
- 54
-
CTL activity of in vitro-derived memory T cells is more efficient than naıve T cells in syngeneic recipients immediately following experimental BMTRoskos, M. / Levy, R. B. et al. | 2005
- 54
-
Reconstitution of immunity to adenovirus after pediatric bone marrow transplantMyers, G. D. / Leen, A. M. / Rooney, C. M. / Heslop, H. E. / Bollard, C. M. et al. | 2005
- 54
-
Cross-reactivity of Epstein Barr virus-specific cytotoxic T lymphocytes with a HLA-C locus alleleKeever-Taylor, C. A. / Ramadan, G. / Orental, R. J. / Davies, B. / Behn, B. / Margolis, D. A. et al. | 2005
- 55
-
Factors underlying early lymphocyte recovery and associated survival benefit following autologous stem cell transplant for lymphoproliferative disordersHill, J. M. / Webber, S. M. / Fitzmaurice, T. F. / Cole, B. F. / Szczepiorkowski, Z. M. / Meehan, K. R. et al. | 2005
- 55
-
The effects of cytotoxic and immunosuppressive agents on thymic reconstitutionProckop, S. E. / O’ / Reilly, R. J. / Petrie, H. T. et al. | 2005
- 55
-
Thymic activity of human growth hormone on murine thymocytes: Potential role in promoting thymopoiesis following bone marrow transplantWelniak, L. A. / Charter, N. S. / Murphy, W. J. et al. | 2005
- 56
-
Major cytotoxic pathways are required for effective resistance against hematopoietic allografts by effector cells derived from naıve but not memory recipient T cellsZimmerman, Z. F. / Levy, R. B. et al. | 2005
- 56
-
Development of B lymphopoiesis after allogeneic stem cell transplantationWinkler, J. / Biller, A. / Roesler, W. / Schaefer-Eckart, K. / Wandt, H. / Schwerdtfeger, R. / Holler, E. / Winkler, T. H. / Gramatzki, M. et al. | 2005
- 56
-
Ex vivo generated myeloid progenitors protect mice from lethal irradiationChristensen, J. L. / Smith, S. / Gille, D. / Domen, J. / Danenberg, E. / Wahedi, M. / Fong, T. et al. | 2005
- 57
-
In vivo dual modality contemporaneous imaging of different tumor reactive T-cell subpopulationsDoubrovin, M. M. / Doubrovina, E. S. / Cai, S. / Blasberg, R. G. / O’ / Reilly, R. J. et al. | 2005
- 57
-
Elimination of alloreactive T lymphocytes using photodynamic therapy prevents the development of GVHD and promotes B and T cell reconstitution after MHC-mismatched transplantationSidi Boumedine, R. / Krosl, G. / Vaillancourt, M. / Perreault, C. / Roy, D. C. et al. | 2005
- 57
-
Keratinocyte growth factor (KGF) is required for post-natal thymic regenerationAlpdogan, O. / Hubbard, V. M. / Muriglan, S. J. / Goldberg, G. L. / Kochman, A. A. / Eng, J. M. / Smith, O. M. / Boyd, R. L. / van den Brink, M. R. et al. | 2005
- 58
-
Allogeneic stem cell transplantation in chronic myeloid leukaemia: Experience at armed forces bone marrow transplant centre-PakistanRaza, S. / Hashmi, K. U. / Khattak, B. K. / Ahmed, P. / Hussain, I. et al. | 2005
- 58
-
Complete chimerism following the use of anti-CD33 antibody in a child with relapsed acute lymphocytic leukemia (ALL) after allogeneic bone marrow transplantation (allo BMT)Odone-Filho, V. / Carvalho, A. / Ramos, R. R. / Conchon, M. / Cristofani, L. M. et al. | 2005
- 58
-
Developement of chronic GvH is the strongest predictor of survival in patients with poor-risk AML in remission after related or unrelated SCTFibich, C. / Luiders, J. / Douglas, S. / Robert, T. A. / Loree, L. / Christopher, B. / Assan, C. / James, R. A. et al. | 2005
- 59
-
Allogeneic stem-cell transplantation in patients with AML and MDS using myeloablative versus reduced-intensity doses of intravenous busulfan (Busulfex): The role of dose intensityShimoni, A. / Yeshurun, M. / Hardan, I. / Avigdor, A. / Shem-Tove, N. / Ben-Bassat, I. / Nagler, A. et al. | 2005
- 59
-
Prognostic progenitor profiling in chronic myelomonocytic leukemiaJamieson, C. H. / Li, K. / Gotlib, J. / Coutre, S. E. / Lagasse, E. / Weissman, I. L. et al. | 2005
- 59
-
Post-remission therapy of acute myeloid leukemia in first remissionKim, S. T. / Kim, K. / Lee, S. H. / Kim, W. S. / Jung, C. W. / Lee, M. H. / Park, K. et al. | 2005
- 60
-
Residual AML at the time of allograft: Outcome analysis based on number of bone marrow blastsHjortsvang, E. W. / Kamble, R. / Kharfan-Dabaja, M. A. / Kern, W. / Ozer, H. / Selby, G. B. et al. | 2005
- 60
-
Promising outcomes of allogeneic cord blood transplant (CBT) for high risk acute lymphoblastic leukemia (ALL) in childrenSawczyn, K. K. / Quinones, R. / Malcolm, J. / Hild, E. / Hansen, S. / Croskell, M. / Sommer, K. / Schissel, D. / Peltz, A. / Pasut, B. et al. | 2005
- 60
-
The use of mouse models of normal and malignant hematopoiesis to design strategies for selective purging of primitive acute myeloid leukemia (AML) progenitorsHogge, D. E. / Wong, S. H. / Yalcintepe, L. / Frankel, A. E. et al. | 2005
- 61
-
High avidity cyclin E1-derived peptide-specific CTL kill lymphoid leukemia cells and cross-recognize a homologous cyclin E2-derived peptideKondo, Y. / Wieder, E. / Lu, S. / Molldrem, J. J. et al. | 2005
- 61
-
Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission statusGutierrez-Aguirre, C. H. / Cantu-Rodriguez, O. G. / Gonzalez-LLano, O. / Salazar-Riojas, R. / Martinez-Gonzalez, O. L. / Jaime-Perez, J. C. / Gomez-Almaguer, D. et al. | 2005
- 61
-
Autologous stem cell transplantation (ASCT) in untreated first relapse (REL1) or following re-induction chemotherapy (CT) for patients (pts) with acute myelogenous leukemia (AML)Pornvipavee, R. / Dierkhising, R. A. / Elliott, M. A. / Hogan, W. J. / Kremers, W. K. / Letendre, L. / Pedersen, R. A. / Tefferi, A. / Litzow, M. R. et al. | 2005
- 62
-
Hematopoietic cell transplantation from unrelated and related donors after a fludarabine-alkylator-based regimen is a reasonable treatment option for older patients (>60 years) with active hematologic malignanciesFinke, J. / Spyridonidis, A. / Ihorst, G. / Gruellich, C. / Zeiser, R. / Bertz, H. et al. | 2005
- 62
-
Gemtuzumab-ozogamicin (GO; Mylotarg®) as part of consolidation therapy for AML before autograft: Low incidence of hepatic veno-occlusive diseaseFernandez, H. F. / Kim, H. T. / Bennett, J. M. / Dewald, G. / Talllman, M. S. / Lazarus, H. M. et al. | 2005
- 62
-
Dysregulation of the γδ T cell repertoire in patients with acute leukemia: Implications for cellular immunotherapyLamb, L. S. et al. | 2005
- 63
-
Identification of novel WT1 epitopes by sensitization of human T cells with overlapping pentadecapeptides spanning the WT1 protein for the targeted adoptive immunotherapy of leukemiaDoubrovina, E. / Dupont, J. / Trivedi, D. / O’ / Reilly, R. J. et al. | 2005
- 63
-
Pretransplant conditioning with IV busulfan (Bu) and fludarabine (Flu) as alternative to Bu and cyclophosphamide (Cy)—a safe, myeloablative regimen with high antileukemic efficacy in AML/MDSde Lima, M. / Couriel, D. / Shahjahan, M. / Alamo, J. / Madden, T. / Thapar, N. / Russell, J. / Anderlini, P. / Giralt, S. / Shpall, E. et al. | 2005
- 64
-
Treatment of posttransplantation diabetes mellitus with anti-CD20 monoclonal antibodiesVandenbosch, K. / Champagne, M. A. / Gonthier, M. / Moghrabi, A. / Vachon, M. F. / Duval, M. et al. | 2005
- 64
-
Intensive immunosuppression and transplantation of T-cell depleted autologous peripheral blood stem cells in patients with systemic sclerosis: An ongoing phase I trialBuchBarker, D. / Donnenberg, A. D. / Medsger, T. A. / Carroll, M. P. / Griffin, D. L. / Blair, C. / Lis, D. / Yeager, A. M. et al. | 2005
- 64
-
CD34+ cells purified autologous peripheral blood stem cell transplantation for the treatment of refractory autoimmune diseasesNagafuji, K. / Miyamoto, T. / Fukuda, T. / Tsukamoto, H. / Horiuchi, T. / Harada, M. et al. | 2005
- 64
-
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Storek, J. / Zhao, Z. / McSweeney, P. A. / Nash, R. A. / Akatsuka, Y. / Sullivan, K. M. / Maloney, D. G. et al. | 2005
- 65
-
Tandem autografts for multiple myeloma patients using two different conditioning regimens: An interim analysisLiu, H. / Roberts, C. / Pumphrey, P. / Wingard, J. R. / Moreb, J. S. et al. | 2005
- 65
-
Consolidation and mobilization of peripheral blood stem cells using high-dose cytarabine and etoposide in acute myeloid leukemia: A single institutional experienceShu, F. / Bashey, A. / Carrier, E. / Castro, J. / Holman, P. / Lane, T. / Medina, B. / Corringham, S. / Ball, E. D. et al. | 2005
- 65
-
Autologous stem cell transplantation (ASCT) for high-risk pediatric solid tumorsFraser, C. J. / Weigel, B. J. / John, P. P. / Todd, D. E. / Kevin, B. S. / Michael, V. R. et al. | 2005
- 66
-
Elevated mean corpuscular volume (MCV) following autologous hematopoietic stem cell transplantation: Incidence and significanceHamadani, M. H. / Kamble, R. / Sethi, S. / Kharfan-Dabaja, M. / Kern, W. / Ozer, H. / Selby, G. B. et al. | 2005
- 66
-
Myeloablative chemotherapy and autologous peripheral stem cell transplantation without the use of blood productsJamal, F. / Lim, S. W. / Vescio, R. / Pepkowitz, S. / Van Strien, P. / Hoshal, K. / Lill, M. C. et al. | 2005
- 66
-
CD34+CD38− and CD34+HLA−DR− contents in BMSC grafts correlate with short-term engraftment but have no influence on long-term hematopoietic recovery in patients who received autologous bone marrow transplantationZubair, A. C. / Kao, G. / Ritz, J. et al. | 2005
- 67
-
HPC in peripheral blood predicts CFU activity and time to engraftment in autologous apheresis PBSC products as effectively as CD34 cell countCreer, M. H. / Regan, D. M. / Saridey, S. K. / Oliver, D. A. et al. | 2005
- 67
-
Experiences of peripheral blood stem cells collection from radial artery for unrelated donor transplantationChen, R. L. / Ro, Y. C. / Yeh, S. Y. / Lin, D. Y. / Hsu, W. L. et al. | 2005
- 67
-
Effect of the number of days required for collection of allogeneic peripheral blood stem cells on engraftmentDevetten, M. P. / Lynch, J. C. / Petersen, K. A. / Kessinger, A. et al. | 2005
- 68
-
Predictive factors for adequate hematopoietic stem cell mobilization with hematopoietic growth factor alone in patients with lymphomaTomblyn, M. / Rogers, T. / Arora, M. / Barker, J. / Brunstein, C. / Burns, L. / Kaufman, D. / McGlave, P. / Miller, J. / Slungaard, A. et al. | 2005
- 68
-
Efficient enrichment and flow sorting of aldehyde dehydrogenase bright hematopoietic progenitor cells from thawed, banked umbilical cord bloodGentry, T. L. / Balber, A. E. / Baucom, C. / Deibert, E. / Haley, N. R. / Pritchard, C. / Hickerson, D. / Carawan, H. / Kaestner, A. / Kurtzberg, J. et al. | 2005
- 69
-
Human mesenchymal stem cells affect IgG production induced by lipopolysaccharide, cytomegalovirus and varicella zoster virus in human spleen cellsRasmusson, I. / Sundberg, B. / Le Blanc, K. / Ringden, O. et al. | 2005
- 69
-
In vitro umbilical cord blood expansion resulting in unique CD34Bright cell population that engrafts in NOD/SCID miceXu, R. / DeLuca, K. / Porter, W. / Garretson, L. / Rowley, J. / Liebmann-Vinson, A. et al. | 2005
- 69
-
Bone marrow–derived mesenchymal cells delay allogeneic rejectionKleiner, G. I. / Gandia, C. / Yu, H. / Kadono, J. / Coats, E. / Defaria, W. / Santiago, S. / Ruiz, P. / Tzakis, A. et al. | 2005
- 69
-
Development of a minimally invasive bone marrow harvest device and method for the rapid extraction of bone marrow for use in bone marrow transplantation and stem cell therapyKraft, D. L. / Milroy, C. / Negrin, R. S. et al. | 2005
- 70
-
Durable engraftment of AMD3100-mobilized hematopoietic stem cells in a canine autologous and allogeneic modelBurroughs, L. / Mielcarek, M. / Little, M. T. / Bridger, G. / MacFarland, R. / Fricker, S. / Sandmaier, B. / Torok-Storb, B. / Storb, R. et al. | 2005
- 70
-
Sufficient numbers of cord blood derived mesenhymal stem cells for transplantation are generated by plastic adhesion or depleting methodsChatzistamatiou, T. K. / Paterakis, G. / Stavropoulos-Giokas, C. / Papassavas, A. C. et al. | 2005
- 70
-
Allogeneic T cells induce cord blood CD34+ or CD133+ cells rapid proliferation and differentiation into dendritic cell precursorsAbbasian, J. / Mahmud, N. / Rondelli, D. et al. | 2005
- 71
-
Evaluation of oral mucositis using a self-reported questionnaire in patients with hematologic malignancies undergoing high-dose chemoradiotherapy followed by peripheral blood progenitor cell transplantationStiff, P. J. / Bensinger, W. I. / Emmanouilides, C. / Gentile, T. / Okano, G. / Lu, J. / Erder, M. H. / Spielberger, R. et al. | 2005
- 71
-
Weight loss in pediatric patients with chronic graft-versus-host disease (cGVHD)Browning, B. / Thormann, K. / Tse, W. / Duerst, R. / Kletzel, M. / Jacobsohn, D. A. et al. | 2005
- 72
-
Risk factors for chronic kidney disease (CKD) after hematopoietic cell transplantation (HCT)Hingorani, S. R. / Guthrie, K. / Schoch, G. / McDonald, G. D. et al. | 2005
- 72
-
Long-term quality of life is not affected by age in AML/MDS patients after allogeneic hematopoietic stem cell transplantationShahjahan, M. / Alamo, J. / Giralt, S. / Detry, M. / Munsell, M. / Estey, E. / Champlin, R. / de Lima, M. et al. | 2005
- 73
-
JC virus reactivation in hemorrhagic cystitis complicating bone marrow transplantation patientsManna, P. / Grantham, K. / Reddy, S. / Nath, R. et al. | 2005
- 73
-
Detection and quantitative Candida load monitoring using molecular beacon probeManna, P. / Grantham, K. / Reddy, S. / Nath, R. / Dalal, J. et al. | 2005
- 74
-
Modeled cost-effectiveness analysis of autologous haemopoietic stem cell transplantation compared with standard dose chemotherapy for relapsed, aggressive non-Hodgkin’s lymphomaPrajogo, J. / Rowlings, P. A. / Neil, A. / Duke, J. / Zhang, H. / Stokes, B. et al. | 2005
- 74
-
Development of a real-time PCR assay to diagnose invasive AspergillosisReddy, S. / Grantham, K. / Nath, R. / Dalal, J. / Manna, P. et al. | 2005
- 74
-
Relationship of BK viral load in blood and urine with the severity of hemorrhagic cystitis (HC) after hematopoietic stem cell transplantation (HSCT)Janbay, N. / De Bari, V. / Manna, P. / Visweshwar, N. / David, C. / Lange, M. / Sterrett, J. R. / Nath, R. et al. | 2005
- 75
-
Phase II trial of GM-CSF as maintenance therapy post–autologous peripheral blood stem cell transplantation in multiple myelomaMandanas, R. A. / Beveridge, R. / Rifkin, R. M. / Greenspan, A. R. / Orloff, G. J. / Klein, L. M. / Rauch, M. A. / Boehm, K. A. / Zhan, F. / Asmar, L. et al. | 2005
- 75
-
GM-CSF and interferon-α maintenance therapy for multiple myeloma patients after autologous stem cell transplantation (ASCT): An interim reportGowda, S. / Cogle, C. R. / Khan, S. A. / Moreb, J. S. et al. | 2005
- 75
-
Allogeneic stem cell transplantation (SCT) using reduced intensity conditioning (RIC) in the patients with recurrent and refractory malignant lymphoproliferative disordersRaida, L. / Faber, E. / Papajik, T. / Indrak, K. / Zapletalova, J. / Vitek, A. / Koza, V. et al. | 2005
- 75
-
Salvage therapy with CDME schedule followed by PBSC transplantation in 20 lymphoma patients: An intention-to-mobilize and transplantation analysisWon, J. H. / Kim, H. J. / Lee, N. S. / Lee, S. H. / Bae, S. B. / Kim, C. K. / Lee, K. T. / Park, S. K. / Hong, D. S. / Park, H. S. et al. | 2005
- 76
-
A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)Gribben, J. G. / Bartlett, N. L. / Stephenson, J. J. / Milder, M. S. / Boccia, R. V. / Redfern, C. / Mizuno, V. M. / Berenson, R. J. / Frohlich, M. W. et al. | 2005
- 76
-
High-dose melphalan (HDM) without hematopoietic progenitor cell (HPC) support for treatment of plasma cell leukemiaHayek, F. N. / Al-Ghawi, H. / Mehta, A. / Herzig, R. H. / Herzig, G. P. et al. | 2005
- 76
-
A phase I/II study of Xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myelomaVij, R. / Vescio, R. A. / Borrello, I. M. / Martin, T. G. / Siegel, D. / Berenson, J. R. / Janmohamed, F. / Berenson, R. J. / Frohlich, M. W. et al. | 2005
- 77
-
Bortezomib does not adversely affect stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantationUy, G. L. / Fisher, N. M. / Devine, S. M. / Adkins, D. R. / Tomasson, M. H. / Graubert, T. A. / DiPersio, J. F. / Vij, R. et al. | 2005
- 77
-
Riches usher dilemmas: Antifungal therapy in invasive aspergillosisChandrasekar, P. et al. | 2005
- 77
-
Survival after autologous transplantation to treat diffuse large B-cell lymphoma with a history of central nervous system involvement, bone marrow involvement, or histological transformationHayes-Lattin, B. / Mehta, P. / Dunn, A. / Subbiah, N. / Leis, J. F. / Simic, A. / Allen, B. / Balleisen, S. / Curtin, P. T. / Epner, E. et al. | 2005
- 78
-
Flow cytometric monitoring of normal plasma cells after autologous stem cell transplantation for multiple myeloma (MM)Liu, H. / Yuan, C. M. / Braylan, R. / Wingard, J. R. / Moreb, J. S. et al. | 2005
- 78
-
Reduction in serum myeloma (M) paraprotein after cyclophosphamide (Cy) mobilization predicts for improved survival after single-agent melphalan (MEL)–based autologous hematopoietic stem cell transplantation (AHSCT)Aggarwal, C. / Shah, H. R. / Salzman, D. E. / Tilden, A. B. / Vaughan, W. P. et al. | 2005
- 78
-
A single institution long-term experience using autologous stem cell transplantation for the management of Hodgkin’s lymphomaSkikne, B. / Thudi, N. / Deauna-Limayo, D. / Ganguly, S. / Bodensteiner, D. / Devine, C. / Cook, J. D. et al. | 2005
- 79
-
Immunotherapy and transplantation for multiple myeloma: Early recovery of aggressive cytotoxic cells and improved immune recoveryBengtson, E. M. / Wu, J. Y. / Fitzmaurice, T. F. / Cornell, C. J. / Ely, P. / Gautier, M. / Lowrey, C. H. / Meehan, K. R. et al. | 2005
- 79
-
Total body irradiation dose and pulmonary toxicity in pediatric patientsKornguth, D. G. / Mahajan, A. / Ka Wah, C. / Antolak, J. / Sanders, K. E. / Borghero, Y. / Chul, H. S. et al. | 2005
- 79
-
Hematopoietic stem cell transplantation is effective curative treatment in pediatric refractory/aggressive Langerhans cell histiocytosisCaniglia, M. / Pinto, R. M. / Rana, I. / Zinno, F. / Peluso, G. / Lombardi, A. / Angioni, A. / Isacchi, G. / Arcese, W. / De Rossi, G. et al. | 2005
- 80
-
Risk factors for liver dysfunction in pediatric hematopoietic stem cell transplantation (HSCT) recipientsSubba Rao, G. / Molleston, J. / Gowan, D. / Haut, P. R. et al. | 2005
- 80
-
Nonmyeloablative conditioning with 200 cGy total body irradiation (TBI) prior to matched littermate allogeneic hematopoietic stem cell transplantation (HSCT) in dogs with canine leukocyte adhesion deficiency results in higher levels of engraftment and donor chimerism compared to busulfan aloneSokolic, R. A. / Burkholder, T. / Tuschong, L. M. / Bacher, J. / Hai, M. / Gu, Y. C. / Bauer, T. R. / Hickstein, D. D. et al. | 2005
- 80
-
Outcomes of unrelated umbilical cord blood transplantation in pediatric patients with myelodysplastic syndromeParikh, S. H. / Martin, P. L. / Szabolcs, P. / Ann, S. / Prasad, V. / Driscoll, T. / Kurtzberg, J. et al. | 2005
- 81
-
Niemann-Pick type B: Successful allogeneic hematopoietic stem cell transplantation with correction of enzyme levelsSchneiderman, J. / Thormann, K. / Kletzel, M. et al. | 2005
- 81
-
Dendritic cell and T-cell subsets correlate with the development and site of acute GVHD following unrelated cord blood transplantation in children: A multivariate analysisSzabolcs, P. / Park, K. D. / Niedzwiecki, D. / Sanders, L. / Lee, Y. A. / Marti, L. / Reese, M. / Kurtzberg, J. et al. | 2005
- 82
-
Engraftment following reduced intensity conditioning (RIC) with FLU-BU-ATG and allogeneic hematopoietic stem cell transplantation (HSCT)—pediatric experience at children’s memorial hospitalDuerst, R. E. / Jacobsohn, D. A. / Tse, W. / Kletzel, M. et al. | 2005
- 82
-
Busulfan dose escalation to increase gene marking of hematopoietic stem cells by lentiviral vectors in infant rhesus monkeysKohn, D. B. / Kahl, C. A. / Lee, C. I. / Jiminez, D. F. / Choi, C. / Pepper, K. A. / Petersen, D. / Fletcher, M. D. / Leapley, A. C. / Burns, T. S. et al. | 2005
- 82
-
EBV-associated leiomyomas following haploidentical transplantation for X-linked severe combined immunodeficiency diseaseRobertson, K. A. / Alturi, S. / Neville, K. / Davis, M. / Marshalleck, F. E. / Buckley, R. H. / Nelson, R. P. et al. | 2005
- 82
-
Results of the cord blood transplantation study (COBLT): Clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with inborn errors of metabolismKurtzberg, J. / Carter, S. L. / Sahdev, I. / Wall, D. / Pietryga, D. / Wagner, J. E. / Kernan, N. A. et al. | 2005
- 83
-
Change of risk factors for treatment-related mortality in children undergoing hematopoietic stem cell transplantation for malignant and nonmalignant diseasesPeters, C. / Lawitschka, A. / Atarbaschi, A. / Lion, T. / Poetschger, U. / Fritsch, G. / Fischer, G. / Rosenmayr, A. / Gadner, H. / Matthes-Martin, S. et al. | 2005
- 83
-
Treatment of pediatric patients with Sanfilippo syndrome (MPS IIIA and IIIB) with unrelated umbilical cord blood transplantationKurtzberg, J. / Szabolcs, P. / Wood, S. / Ciocci, G. / Driscoll, T. / Prasad, V. / Parikh, S. / Martin, P. L. / Allison, J. / Escolar, M. L. et al. | 2005
- 84
-
Targeted radiotherapy to the skeleton using 166Ho-DOTMP with autologous stem cell transplantation for patients with bone-only metastatic breast cancerChamplin, R. E. / Booser, D. / Rondon, G. / Williams, P. A. / Wendt, R. / Hortobagyi, G. / Ueno, N. / Podoloff, D. et al. | 2005
- 84
-
Low transplant-related mortality after stem cell transplantation with IV busulfan-based conditioning in pediatric patientsBolotin, E. / Cooper, L. / Synold, T. / Sweetman, R. / Mao, J. / Palmer, J. / Rosenthal, J. et al. | 2005
- 84
-
Reduced toxicity myeloablative conditioning regimen for children with marrow stem cell defects (MSCD) or leukemiaHorn, B. / Baxter-Lowe, L. A. / McMillan, A. / Quinn, M. / DeSantes, K. / Cowan, M. et al. | 2005
- 85
-
Tandem high-dose chemotherapy (HDC) with peripheral blood stem cell rescue (PBSCR) as consolidation therapy for high-risk (primary unresectable pelvic tumors or metastatic disease) Ewing’s sarcoma patientsBurke, M. J. / Kletzel, M. / Jacobsohn, D. A. / Duerst, R. E. et al. | 2005
- 85
-
CD133-positive hematopoietic stem cells “stemness” genes contain many genes mutated or abnormally expressed in leukemiaToren, A. / Bielorai, B. / Jacob-Hirsh, J. / Fisher, T. / Kreiser, D. / Zelikovsky, S. / Givol, D. / Itskovitz-Eldor, J. / Rosenthal, E. / Amariglio, N. et al. | 2005
- 85
-
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemiaOehler, V. G. / Radich, J. P. / Storer, B. / Blume, K. G. / Chauncey, T. / Clift, R. / Snyder, D. S. / Forman, S. J. / Flowers, M. E. / Martin, P. et al. | 2005
- 85
-
Pleiotrophin is a key switch of human monocytes and bone marrow stem cells into endotherlial-like cells for angiogenesis in tumor growthChen, H. / Zhu, D. / Campbell, R. A. / Pan-James, C. / Wang, C. S. / Gordon, M. S. / Bonavida, B. / Berenson, J. R. et al. | 2005
- 86
-
Bone marrow stem cell transplantation in neurodegenerative and cerebrovascular disease: Preliminary reportOzbabalik, D. B. / Gulbas, Z. / Adapinar, B. / Ak, I. / Gulel, B. et al. | 2005
- 86
-
Effects and kinetics of anti–c-kit monoconal antibody ACK-2 on hematopoiesis and hematopoietic progenitors and its ability to condition for bone marrow transplantationKraft, D. L. / Weissman, I. L. et al. | 2005
- 86
-
Bioluminescent tracking of candidate leukemic stem cell engraftment in immunocompromised miceJamieson, C. H. / Karimi, M. / Creusot, R. / Fathman, C. G. / Negrin, R. / Weissman, I. L. et al. | 2005
- 87
-
Vanganciclovir prophylaxis for the prevention of cytomegalovirus reactivation and disease in allogeneic stem cell transplantation recipientsMagalhaes-Silverman, M. / Carter, T. / Hohl, R. / Shamsuddin, H. / Gingrich, R. et al. | 2005
- 87
-
Epithelial chimerism in the oral mucosa after human hematopoietic cell transplantationSpyridonidis, A. / Zeiser, R. / Metaxas, Y. / Faber, P. / Finke, J. et al. | 2005
- 87
-
Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myelomaOlin, R. L. / Luger, S. M. / Porter, D. L. / Schuster, S. J. / Tsai, D. / Nasta, S. / Perl, A. / Loren, A. W. / Goldstein, S. / Mangan, P. et al. | 2005
- 88
-
Voriconazole (VOR) is safe and effective as prophylactic antifungal therapy for allogeneic stem cell transplantation (AT)Martin, T. / O’ / Malley, R. / Working, M. / Guglielmo, J. / Fischbach, N. / Damon, L. / Navarro, W. / Kaplan, L. / Linker, C. et al. | 2005
- 88
-
Ursodiol-based prophylaxis for veno-occlusive disease (VOD): A retrospective risk-based review of outcomes following allogeneic stem cell transplantationThompson, J. M. / Akard, L. P. / Dugan, M. J. / English, K. / Jansen, J. et al. | 2005
- 88
-
Actualizing a wellness program and wellness room in the oncology setting: Getting a program through a large institutionGalgay, L. / Swift, S. / Cusack, G. / Jones-Wells, A. / Rivera, P. / Chisholm, L. et al. | 2005
- 89
-
Pharmacokinetics of high-dose weekly Ambisome (liposomal amphotericin B) antifungal prophylaxis in pediatric bone marrow transplantation (BMT) patientsMehta, P. A. / Vinks, A. A. / Filipovich, A. H. / Vaughn, G. A. / Fearing, D. N. / Sper, C. / Davies, S. M. et al. | 2005
- 89
-
Antifungal prophylaxis with voriconazole in allogeneic hematopoietic stem cell transplantation recipientsMagalhaes-Silverman, M. / Carter, T. / Hohl, R. / Shamsuddin, H. / Gingrich, R. et al. | 2005
- 89
-
Evaluation of antibiotic cycling and prophylaxis for neutropenic fever within a blood and marrow transplantation unitCraig, M. / Cumpston, A. / Shields, R. / Devetten, M. / Sarwari, A. / Ericson, S. et al. | 2005
- 90
-
Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantationBachier, C. / Shaughnessy, P. / Wall, D. / Grimley, M. / Carrum, G. / Freytes, C. / Callander, N. / Walsh, T. / LeMaistre, C. F. et al. | 2005
- 90
-
Safety of bisphosphonate use in hematopoietic progenitor cell transplantation in multiple myeloma patientsMazj, S. / Ng, N. / Lichtman, S. M. / John, V. / Devoe, C. / Bayer, R. L. et al. | 2005
- 90
-
Single center experience with collection and administration of G-CSF–mobilized, irradiated granulocyte transfusions from directed donors to support patients at high risk for infections undergoing unrelated donor blood and marrow transplantationAllison, J. / Stephens, C. / Waters-Pick, B. / Bradshaw, T. / Whitlock, P. / Kurtzberg, J. et al. | 2005
- 91
-
Preemptive therapy with ganciclovir and short-course intravenous immunoglobulin does not prevent recurrent cytomegalovirus infection (CBMTG-102 study)Hasegawa, W. S. / Pond, G. R. / Dranitsaris, G. / Jenkins, G. G. / Couban, S. / Walker, I. R. / Lipton, J. H. et al. | 2005
- 91
-
Phase I trial of CG53135-05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT)Schuster, M. W. / Shore, T. B. / Harpel, J. / Greenberg, J. / Jalilizeinali, B. / Possley, S. / Halvorsen, Y. D. / Annino, V. I. / Hahne, W. et al. | 2005
- 92
-
AMD3100 plus G-CSF rapidly mobilizes hematopoietic progenitor cells in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM), including those traditionally considered “poor mobilizers”Stiff, P. / Micallef, I. / McCarthy, P. / Magalhaes-Silverman, M. / Fromenberg, N. / Weisdorf, D. / Tricot, G. / Territo, M. / Abodnour, R. / Badel, K. et al. | 2005
- 92
-
Influence of immunosuppressive agents on magnesium (Mg) metabolism after allogeneic hematopoietic stem cell transplantation (HSCT): Comparison between cyclosporine a (CSA) and tacrolimusAisa, Y. / Mori, T. / Shimizu, T. / Yamazaki, R. / Yamane, A. / Adachi, A. / Yokoyama, A. / Nakazato, T. / Ikeda, Y. / Okamoto, S. et al. | 2005
- 92
-
Twice-weekly ABLC prophylaxis for patients at high risk of invasive fungal infection after allogeneic stem cell transplantationJansen, J. / Akard, L. P. / Wack, M. F. / Thompson, J. M. / Dugan, M. J. / Leslie, J. K. / Mattison, R. H. et al. | 2005
- 93
-
The effects of hyperglycemia on hematopoietic stem cell transplantationMosallaei-Benjamin, M. / Hamadani, M. / Scofield, H. / Holla, P. / Selby, G. et al. | 2005
- 93
-
Posaconazole (POS) salvage therapy allows successful allogeneic hematopoietic stem cell transplantation (HSCT) in patients with refractory invasive mold infectionsMullane, K. / Toor, A. c. / Rodriguez, T. c. / Kalnicky, C. / Klein, J. c. / Stiff, P. c. et al. | 2005
- 93
-
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvementKasamon, Y. L. / Jones, R. J. / Piantadosi, S. / Ambinder, R. F. / Abrams, R. A. / Borowitz, M. J. / Morrison, C. / Smith, B. D. / Flinn, I. W. et al. | 2005
- 93
-
Shared medical appointments (SMA): Implementation in the bone marrow transplantation clinicMeehan, K. R. / Root, L. / Kimtis, E. A. / Patchett, L. / Hill, J. M. et al. | 2005
- 94
-
Respiratory syncytial virus infections in allogeneic HSCT patients: Effective antiviral therapy eliminates acute mortality, but infection-related lung injury may predispose to subsequent pulmonary complicationsQuinones, R. / Hild, E. / Malcolm, J. / Foreman, N. / Garcea, R. / Gore, L. / Peltz, A. / Pasut, B. / Van Stelle, J. / Adams, J. et al. | 2005
- 94
-
Reducing costs without compromising quality in the pediatric allogeneic transplantation settingFisher, V. L. / Ellerbrock, K. / Casey, F. / Nieder, M. et al. | 2005
- 94
-
Ganciclovir and high-dose valacyclovir reduce cytomegalovirus reactivation in patients receiving allogeneic stem cell transplantation with Campath-1H–based conditioning regimensKline, J. P. / Pollyea, D. / Artz, A. S. / Stock, W. / Rich, E. / Godley, L. A. / Zimmerman, T. / van Besien, K. et al. | 2005
- 95
-
Factors influencing cancellation of an allogeneic bone marrow transplantation: A single-center studyLanther, T. / Sengelov, H. et al. | 2005
- 95
-
Competing on quality: Identifying performance indicators and outcomes for pediatric stem cell transplantationQuinn, M. A. et al. | 2005
- 95
-
Impact of multidisciplinary care in improving outcomes in multiple myeloma patients receiving outpatient autologous peripheral blood stem cell transplantationAtmar, J. S. / Shah, H. B. / Nash, V. et al. | 2005
- 96
-
Parents rooming-in during their child’s hematopoietic stem cell transplantationVachon, M. F. / Richer, J. / Dalle, J. H. / Duval, M. / Champagne, M. A. et al. | 2005
- 96
-
Bioethics in blood and marrow transplantation (BMT): Advanced care planning and advanced directive (AD)Neumann, J. L. / Smith, M. / Causton, C. / Hosing, C. et al. | 2005
- 96
-
Late effects of stem cell transplantation compared to chemotherapy/radiation reported by survivors in a web-based surveyBarnes, Y. J. / Hauff, M. / Shenoy, S. et al. | 2005
- 97
-
The nursing shortage: The Duke Pediatric Stem Cell Tranplant Program Nursing Recruitment and Retention ProgramFrey, M. A. / Talbert, G. et al. | 2005
- 97
-
Combined home enzyme replacement therapy and unrelated cord blood transplantation for Hurler’s syndrome (MPSI) in a pediatric HSCT centerRodriguez, M. / Khimji, I. / Rhodd, S. / Lapage, C. / Zalesky, L. / Jimenez, P. / Barbouth, D. / Elsas, L. / Kleiner, G. et al. | 2005
- 97
-
Preadmission stem cell transplantation teaching: A team aproachScherer, T. M. / Wheeler, A. et al. | 2005
- 97
-
Herpes simplex virus in the pediatric bone marrow and stem cell transplantation patientBlackstock, J. L. / Parikh, S. H. / Talbert, J. G. et al. | 2005
- 98
-
Treatment options and nursing care for the pediatric aplastic anemia patient requriring bone marrow or stem cell transplantationBaker, J. H. / Frey, M. A. / Kurtzberg, J. et al. | 2005
- 98
-
Subjective symptoms and performance status of survivors of hematopoietic stem cell transplantationChoi, S. E. / Kim, K. S. / Bok, G. N. et al. | 2005
- 98
-
Open all night? Visiting hours on bone marrow transplantation unitsRees, L. F. et al. | 2005
- 98
-
Assessing for Nutritional Risk Factors on a bone marrow transplantation unitSzewczyk, N. A. et al. | 2005
- 99
-
HLA made simple: Chromosomes, genes, and alleles, oh myMattox, S. / Stewart, D. / Gibson-Steed, M. et al. | 2005
- 99
-
Another season of sneezing: Respiratory syncytial virus revisitedMeyers, A. L. / Neumann, J. / Gonzalez, V. et al. | 2005
- 99
-
Outpatient total body irradiation (TBI) in the pediatric bone marrow transplantation patientGiller, R. H. / Van Stelle, J. L. / Hinote, M. J. / Hild, E. / Malcolm, J. / Kissane, R. / Quinones, R. et al. | 2005
- 99
-
The role of patient education in the safe management of autologous HSCT patients in an outpatient settingHamelin, L. / McDiarmid, S. / Huebsch, L. et al. | 2005
- 100
-
Celebration of life: The first blood and marrow transplantation survivor’s day at one of the largest transplantation centers in the countryAdornetto, D. L. / Denman, C. / Bourne, L. et al. | 2005
- 100
-
Mentoring: “Bridging the gap” for transplantation coordinators in one of the largest transplantation programs in the countryStary, S. J. / Zabawa, S. / Calamusa, J. / Adornetto, D. L. et al. | 2005
- 100
-
Quality improvement: A truly interdisciplinary approachSorensen, S. H. / Adornetto, D. L. et al. | 2005
- 100
-
Infection in the pediatric patient after bone marrow or stem cell transplantation: Nursing considerationsKokoszka, A. K. / Frey, M. A. / Talbert, G. / Martin, P. L. et al. | 2005
- 101
-
Utilizing the town meeting forum to involve caregivers of pediatric patients undergoing bone marrow and stem cell transplantationTalbert, G. / Frey, M. A. et al. | 2005
- 101
-
Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host diseaseGoldberg, J. / Jacobsohn, D. A. / Zahurak, M. L. / Vogelsang, G. B. et al. | 2005
- 101
-
The safe administration of undiluted etoposide in the pediatric blood and marrow transplantation patientFisher, V. L. / Kistler, K. / Rowbottom, L. / Hegyi, K. / Heinrich, M. et al. | 2005
- 101
-
Empowering BMT nurses to speak up and be heardRivera, Z. R. / Neumann, J. L. et al. | 2005
- 101
-
Adenovirus infection in pediatric bone marrow transplantation: Nursing considerationsStokyhuzen, A. / Frey, M. / Prasad, V. et al. | 2005
- 102
-
Pediatric blood and marrow transplantation: A roadmap to school reentryFisher, V. L. / Rauhe, M. et al. | 2005
- 102
-
Alternative management of hemorrhagic cystitis with hyperbaric oxygen therapy and activated factor VII in the allogeneic BMT patientTischhauser, T. / Denning, A. J. / Neumann, J. et al. | 2005
- 102
-
Nurse retention in the BMT setting: One possible solutionClegg, C. E. et al. | 2005
- 102
-
Tools to assist with the medication management of hospitalized BMT patientsGrill, K. / Mishaw, K. et al. | 2005
- 103
-
The experience of intensive care unit for hemato-oncology patientsKim, H. J. / Youn, J. H. / Shim, S. M. / Hong, E. Y. / Kim, K. S. / Ban, J. Y. / Han, S. S. / Cho, H. S. / Song, B. E. et al. | 2005
- 103
-
Understanding veno-occlusive disease in the blood and marrow transplantation population: The nurse’s roleBrandert, M. / Ippoliti, C. et al. | 2005
- 103
-
A competency-based orientation tool for initial orientation to the care of blood and marrow transplantation patientsGriffin, J. M. / Brauning, N. / Kehoe, B. / Poonoosamy, S. et al. | 2005
- 103
-
The nurse’s role as coordinator in the safe and effective management of patients with comorbidities undergoing allogeneic stem cell transplantationRamos, C. / Cook, L. / Shelburne, N. / Bevans, M. et al. | 2005
- 104
-
Human herpesvirus 6 (HHV6) infection and reactivation in the pediatric patient after allogeneic transplantation: Nursing education and implications for patient careSickel, A. D. / McConnell, C. L. et al. | 2005
- 104
-
Management of cytomegalovirus in the pediatric bone marrow/stem cell transplantation populationStanton, T. J. / Martin, P. L. / Talbert, G. et al. | 2005
- 104
-
Current therapies utilized in the treatment of the pediatric neuroblastoma patientGurganus, K. J. / Frey, M. A. / Driscoll, T. et al. | 2005
- 104
-
Improving skin care of the pediatric bone marrow and stem cell transplantation patientSmith, M. L. / Frey, M. A. et al. | 2005
- 105
-
Breast-feeding during infant hematopoietic stem cell transplantationHenry, C. / Lavigne, M. J. / Robitaille, M. / Vachon, M. F. / Dalle, J. H. / Duval, M. / Champagne, M. A. et al. | 2005
- 106
-
Efficacy of fluconazole prophylaxis for autologous peripheral blood stem cell transplantation: Results of a prospective, randomized, controlled, multicenter, open label studyWalsh, T. L. / Bachier, C. / Shaughnessy, P. / Freytes, C. O. / Callander, N. / LeMaistre, C. F. / Grimley, M. / Bradshaw, P. et al. | 2005
- 106
-
Multidisciplinary program to assess utilization of voriconazole in a tertiary care teaching medical centerKennedy, L. D. / Williamson, J. / Ohl, C. / Hurd, D. et al. | 2005
- 106
-
Cyclosporine disposition in pediatric hematopoietic stem cell transplantation patients after IV and oral administrationDupuis, L. L. / Taylor, T. / Saunders, E. F. et al. | 2005
- 107
-
Impact of infectious complications on the outcome in patients with hematopoietic stem cell transplantationRhee, J. Y. / Kim, S. T. / Jang, E. H. / Ki, H. K. / Moon, C. S. / Lee, S. H. / Oh, W. S. / Kim, K. H. / Kim, W. S. / Jung, C. W. et al. | 2005
- 107
-
Data connection: www.datamanager.blogspot.com. A clinical research professionals and data manager networkLaursen, H. B. / Bellman, D. / McCrae, J. / Knutson, D. / Rogers, J. M. / Manion, K. L. et al. | 2005
- 107
-
An adaptive Bayesian design for a randomized trial of high- versus low-level tacrolimus as prophylaxis for graft-versus-host disease in allogeneic stem cell transplantationThall, P. F. / Wooten, L. H. / Couriel, D. R. / Champlin, R. E. et al. | 2005
- 108
-
Hematopoietic cell transplantation (HCT) information center: A data management system and a gateway to standard statisticsSaracino, G. / Pineiro, L. / Berryman, B. R. / Fay, J. W. / Vance, E. A. / Woelfel, R. G. / Balderas, M. / Agura, E. D. et al. | 2005
- 108
-
Core information reported to donor centers after allogeneic stem cell transplantation (SCT)Laursen, H. B. / Lanther, T. / Holder, J. et al. | 2005
- 108
-
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantationWong, R. / Shahjahan, M. / Wang, X. / Thall, P. F. / de Lima, M. / Khouri, I. / Gajewski, J. / Alamo, J. / Couriel, D. / Andersson, B. S. et al. | 2005
- 109
-
Author index| 2005
- 115
-
High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosisSteward, C. G. / Blair, A. / Moppett, J. / Clarke, E. / Virgo, P. / Lankester, A. / Burger, S. R. / Sauer, M. G. / Flanagan, A. M. / Pamphilon, D. H. et al. | 2005
- 122
-
Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remissionLee, S. H. / Lee, M. H. / Lee, J. H. / Min, Y. H. / Lee, K. H. / Cheong, J. W. / Lee, J. / Park, K. W. / Kang, J. H. / Kim, K. et al. | 2005
- 129
-
Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphomaLaudi, N. / Arora, M. / Burns, L. J. / Miller, J. S. / McGlave, P. B. / Barker, J. N. / Ramsay, N. K. / Orchard, P. J. / MacMillan, M. L. / Weisdorf, D. J. et al. | 2005
- 136
-
Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantationFries, B. C. / Riddell, S. R. / Kim, H. W. / Corey, L. / Dahlgren, C. / Woolfrey, A. / Boeckh, M. et al. | 2005
- 149
-
Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT)Cornetta, K. / Laughlin, M. / Carter, S. / Wall, D. / Weinthal, J. / Delaney, C. / Wagner, J. / Sweetman, R. / McCarthy, P. / Chao, N. et al. | 2005
-
Purpose & scope| 2005
-
Table of contents| 2005
-
Masthead (Purpose and scope)| 2005
-
Abstracts from the 2005 Tandem BMT meetings| 2005
-
Contents| 2005
-
Masthead| 2005
-
Officers and directors of ASBMT| 2005
-
Editorial board| 2005
-
Supplement title page| 2005